$35.81
0.79% today
Nasdaq, Aug 22, 04:49 pm CET
ISIN
US8688731004
Symbol
SRDX

Surmodics Inc Stock price

$36.09
+4.92 15.78% 1M
+1.24 3.56% 6M
-3.51 8.86% YTD
-3.97 9.91% 1Y
+1.64 4.76% 3Y
-10.26 22.14% 5Y
+12.26 51.45% 10Y
-1.69 4.47% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
-0.81 2.20%

Key metrics

Basic
Market capitalization
$516.0m
Enterprise Value
$512.9m
Net debt
positive
Cash
$32.7m
Shares outstanding
14.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.3 | 4.4
EV/Sales
4.3 | 4.3
EV/FCF
negative
P/B
4.6
Financial Health
Equity Ratio
66.6%
Return on Equity
-9.7%
ROCE
-1.0%
ROIC
-1.3%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$120.8m | $118.0m
EBITDA
$2.1m | $8.3m
EBIT
$-1.4m | $-16.4m
Net Income
$-17.6m | $-8.0m
Free Cash Flow
$-3.6m
Growth (TTM | estimate)
Revenue
0.0% | -6.4%
EBITDA
289.9% | 431.0%
EBIT
68.4% | -739.5%
Net Income
-1,159.3% | 31.0%
Free Cash Flow
39.3%
Margin (TTM | estimate)
Gross
73.1%
EBITDA
1.7% | 7.0%
EBIT
-1.2%
Net
-14.6% | -6.8%
Free Cash Flow
-2.9%
More
EPS
$-1.2
FCF per Share
$-0.2
Short interest
2.8%
Employees
389
Rev per Employee
$320.0k
Show more

Is Surmodics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Surmodics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Surmodics Inc forecast:

4x Hold
57%
3x Sell
43%

Analyst Opinions

7 Analysts have issued a Surmodics Inc forecast:

Hold
57%
Sell
43%

Financial data from Surmodics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
121 121
0% 0%
100%
- Direct Costs 33 33
4% 4%
27%
88 88
1% 1%
73%
- Selling and Administrative Expenses 52 52
1% 1%
43%
- Research and Development Expense 35 35
10% 10%
29%
2.07 2.07
290% 290%
2%
- Depreciation and Amortization 3.51 3.51
1% 1%
3%
EBIT (Operating Income) EBIT -1.45 -1.45
68% 68%
-1%
Net Profit -18 -18
1,159% 1,159%
-15%

In millions USD.

Don't miss a Thing! We will send you all news about Surmodics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surmodics Inc Stock News

Positive
The Motley Fool
14 days ago
Surmodics (SRDX) Q3 EPS Turns Positive
Neutral
Business Wire
14 days ago
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its third quarter ended June 30, 2025, and updated its financial guidance for the fiscal year ending September 30, 2025. Third Quarter Fiscal 2025 Financial Summary Total Revenue of $29.6 ...
Neutral
Business Wire
16 days ago
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that third quarter of fiscal year 2025 financial results will be released before the market opens on Friday, August 8. Given the pending acquisition by GTCR, Surmodics will not be hosting a live webcast and c...
More Surmodics Inc News

Company Profile

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Head office United States
CEO Gary Maharaj
Employees 389
Founded 1979
Website www.surmodics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today